High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coli

Journal of Clinical Microbiology

Volumn 50, Issue 10, 2012, Pages 3202-3207

  Gibreel, Tarek M ^a   Dodgson, Andrew R ^a,b   Cheesbrough, John ^c   Bolton, Frederick J ^d   Fox, Andrew J ^c   Upton, Mathew ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL PRESTON HOSPITAL   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLYASE; PEPTIDASE;

ALKALINIZATION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHEMICAL ANALYSIS; COMMUNITY SUCCESSION; GENETIC LINE; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUTRIENT AVAILABILITY; PRIORITY JOURNAL; UNITED KINGDOM; URINARY TRACT; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; ENGLAND; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE; VIRULENCE FACTORS;

ESCHERICHIA COLI;

EID: 84866441791     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01423-12     Document Type: Article

References (31)

1. Alteri CJ, Smith SN, Mobley HL. 2009. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog. 5:e1000448. doi:10.1371/journal.ppat.1000448.
2. Anfora AT, Haugen BJ, Roesch P, Redford P, Welch RA. 2007. Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073. Infect. Immun. 75:5298-5304. (Pubitemid 350033617)
3. Brauner A, et al. 1987. The use of biochemical markers, serotype and fimbriation in the detection of Escherichia coli clones. J. Gen. Microbiol. 133:2825-2834. (Pubitemid 17153860)
4. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612.
5. Ewing W, Edwards PR. 1986. The genus Escherichia, p 67-107. In Identification of Enterobacteriacae, 4th ed. Burgess, Minneapolis, MN.
6. Farmer JJ, III, et al. 1985. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J. Clin. Microbiol. 21:46-76.
7. Fukasawa K, Hiraoka BY, Fukasawa KM, Harada M. 1982. Arylamidase activities specific for proline, tyrosine, and basic amino acid residues in some oral bacteria. J. Dent. Res. 61:818-820.
8. Gibreel TM, et al. 2012. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J. Antimicrob. Chemother. 67:346-356.
9. Godbout-DeLasalle F, Higgins R. 1986. Biotyping of clinical isolates of Escherichia coli of animal origin, using the Analytab API 20E system. Can. J. Vet. Res. 50:418-421.
10. Johnson JR. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:80-128. (Pubitemid 21920389)
11. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
12. Katouli M, Kuhn I, Mollby R. 1990. Evaluation of the stability of biochemical phenotypes of Escherichia coli upon subculturing and storage. J. Gen. Microbiol. 136:1681-1688. (Pubitemid 20291265)
13. Kuhnert P, Boerlin P, Frey J. 2000. Target genes for virulence assessment of Escherichia coli isolates from water, food and the environment. FEMS Microbiol. Rev. 24:107-117. (Pubitemid 30047117)
14. Lau SH, et al. 2008. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J. Clin. Microbiol. 46:1076-1080.
15. Lavigne JP, et al. 2012. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7:e34294. doi:10.1371/journal. pone.0034294.
16. Le Bouguenec C, Schouler C. 2011. Sugar metabolism, an additional virulence factor in enterobacteria. Int. J. Med. Microbiol. 301:1-6.
17. Leclercq A, Lambert B, Pierard D, Mahillon J. 2001. Particular biochemical profiles for enterohemorrhagic Escherichia coli O157:H7 isolates on the ID 32E system. J. Clin. Microbiol. 39:1161-1164. (Pubitemid 32209743)
18. Leflon-Guibout V, et al. 2008. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coliisolates from healthy subjects living in the area of Paris, France. J. Clin. Microbiol. 46:3900-3905.
19. Liljestrom PL, Liljestrom P. 1987. Nucleotide sequence of the melA gene, coding for alpha-galactosidase in Escherichia coli K-12. Nucleic Acids Res. 15:2213-2220.
20. Moreno E, et al. 2009. Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect. 11:274-280.
21. Nicolas-Chanoine MH, et al. 2008. Intercontinental emergence of Escherichiacoli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
22. Pancholi V, Chhatwal GS. 2003. Housekeeping enzymes as virulence factors for pathogens. Int. J. Med. Microbiol. 293:391-401. (Pubitemid 38082345)
23. Peirano G, Pitout JD. 2010. Molecular epidemiology of Escherichia coliproducing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316-321.
24. Roesch PL, et al. 2003. Uropathogenic Escherichia coli use d-serine deaminase to modulate infection of the murine urinary tract. Mol. Microbiol. 49:55-67. (Pubitemid 36792003)
25. Rooney PJ, et al. 2009. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichiacoli. J. Antimicrob. Chemother. 64:635-641.
26. Roos V, Schembri MA, Ulett GC, Klemm P. 2006. Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology 152:1799-1806.
27. Tenover FC, Arbeit RD, Goering RV. 1997. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect. Control Hosp. Epidemiol. 18:426-439. (Pubitemid 127470994)
28. Toh H, et al. 2010. Complete genome sequence of the wild-type commensal Escherichia coli strain SE15, belonging to phylogenetic group B2. J. Bacteriol. 192:1165-1166.
29. Totsika M, et al. 2011. Insights into a multidrug resistant Escherichia colipathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 6 : e26578. doi:10.1371/journal.pone.0026578.
30. Vidal-Navarro L, Pfeiffer C, Bouziges N, Sotto A, Lavigne JP. 2010. Faecal carriage of multidrug-resistant Gram-negative bacilli during a non-outbreak situation in a French university hospital. J. Antimicrob. Chemother. 65:2455-2458.
31. Zhang L, Foxman B, Manning SD, Tallman P, Marrs CF. 2000. Molecular epidemiologic approaches to urinary tract infection gene discovery in uropathogenic Escherichia coli. Infect. Immun. 68:2009-2015. (Pubitemid 30164831)